Late-Stage Breast Cancer Diagnosis on Rise in U.S.

Gratitude is actively practiced, even amidst personal losses and living with metastatic cancer, highlighting its importance ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
The company's ‘Zeta” platform encompasses the following oncological drug candidates ZetaMet™ (Zeta-BC-003), ZetaMet-P™ (Zeta-PC-004) and ZetaMAST™ (Zeta-MBC-005). To learn more, visit www.zetagen.com ...
A young mom was diagnosed with stage four metastatic breast cancer takes part in an experimental treatment with the help of a doctor at Moffitt Cancer Center.
This roundup includes a selection of abstracts on early and metastatic breast cancer presented at the 2024 San Antonio Breast ...
A bispecifics can unseat Keytruda. | BioNTech reported an 18-month overall survival rate of 69.7%, beating the cross-trial ...
Pembrolizumab plus fulvestrant provided disease control in 50% of patients with ER-positive, HER2-negative metastatic breast cancer.
Palazestrant, in combination with ribociclib, demonstrated promising clinical activity, a safety profile consistent with ribociclib and endocrine ...
Elacestrant, a selective estrogen receptor degrader, demonstrated significant improvements in progression-free survival (PFS) ...
Acceptance and commitment therapy (ACT) significantly decreased fatigue interference and improved quality of life in patients ...